查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1990510

冠状动脉绕道手术手术器械市场：依产品类型、移植类型、手术类型和最终用户划分－2026-2032年全球市场预测

Coronary Artery Bypass Graft Devices Market by Product Type, Graft Type, Procedure Type, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，冠状动脉绕道手术手术装置市场价值将达到 158.6 亿美元，到 2026 年将成长至 168.1 亿美元，到 2032 年将达到 249.2 亿美元，复合年增长率为 6.66%。

主要市场统计数据
基准年 2025 158.6亿美元
预计年份：2026年 168.1亿美元
预测年份 2032 249.2亿美元
复合年增长率 (%) 6.66%

这是一份清晰权威的冠状动脉绕道手术手术装置市场趋势分析报告，系统性地阐述了临床重点、技术进步和相关人员的期望。

冠状动脉绕道手术手术器械领域在心血管外科手术中扮演着核心角色，它需要在既有的外科手术实践与持续的技术进步之间寻求平衡。临床医生继续依赖成熟的技术，而器械製造商和医疗系统则致力于推进渐进式和颠覆性创新，以提高手术安全性、减少手术全期手术期併发症并缩短恢復时间。在此背景下，相关人员如今将临床疗效、易用性和供应链韧性视为影响器材应用决策的同等重要因素。

临床偏好的变化、技术整合以及供应链韧性如何共同重塑冠状动脉绕道手术 (CABG) 治疗中的设备选择、部署和筹资策略？

冠状动脉绕道手术手术器械领域正经历着变革性的转变，这主要归因于临床、技术和操作等多方面因素的共同作用。微创手术和非体外循环技术的出现，刺激了对专用吻合器和稳定器的需求，这些器械和稳定器旨在提高在有限手术视野下操作的精确度。同时，心肺体外迴圈系统的改进也更加重视便携性、生物相容性和降低发炎反应。这些趋势正在重新定义手术室和心臟中心的采购标准，促使医疗机构在评估资本投资时，权衡预期的临床效益和工作流程效率。

评估美国在 2025 年实施的关税措施对 CABG 器械供应链选择、製造本地化和采购惯例的累积影响。

美国于2025年推出的关税政策对冠状动脉绕道手术手术（CABG）器械的价值链产生了累积影响，迫使製造商和买家重新评估其供应商和製造地。关税的分阶段上调提高了进口器械组件和成品的接收成本，进而影响了医院和门诊手术中心的采购决策。为因应这一变化，多家国际供应商调整了其商业策略，采取了扩大区域生产能力、重新谈判供应商合约以及加快对本地组装业务的投资等措施，以保持竞争力。

多方面的细分洞察，解释了产品类型、移植选择、手术方式和最终用户趋势如何影响设备的开发、采用和采购。

冠状动脉绕道手术手术器械领域的细分揭示了创新、临床偏好和采购优先事项的交汇点。根据产品类型，该领域包括吻合器、心肺体外迴圈系统、钳夹和闭塞器以及稳定器。吻合器进一步细分为压迫式吻合环和缝合器；心肺体外迴圈系统细分为可携式系统和标准心肺体外迴圈系统；钳夹和闭塞器细分为主动脉钳和血管闭塞器；稳定器为机械稳定器和吸力稳定器器。这种产品层面的细分使相关人员能够将手术要求与器械功能相匹配，并评估一次性便利性和可重复使用设备之间的权衡。

美洲、欧洲、中东和非洲以及亚太地区的趋势和采用情况存在区域差异，这正在影响临床实践和供应商策略。

区域趋势对冠状动脉绕道手术手术装置的临床实务模式、监管路径和筹资策略有显着影响。在美洲，临床中心通常需要在高度发展的三级医疗网络和多样化的采购模式之间取得平衡，这些模式涵盖了从集中式联合采购组织到医院层面采购等多种模式，从而为能够提供临床证据和服务支援的供应商创造了竞争环境。在欧洲、中东和非洲，监管协调的努力、多样化的报销环境以及医院能力的差异导致了器械应用方面的差异。一些高容量医疗机构正在推动临床创新，而另一些机构则优先考虑成本控制和器材可靠性。

竞争与合作并存的企业动态凸显了成熟企业、专业创新者和新参与企业如何推动产品演进、临床试验和商业性差异化。

冠状动脉绕道手术手术器材领域的竞争动态呈现出多元化的态势，既有成熟的跨国医疗设备公司，也有专注于特定领域的创新专业外科器材企业，以及灵活敏捷、致力于创新的Start-Ups。成熟的医疗设备製造商凭藉着广泛的临床关係、完善的服务网络和丰富的监管经验，维持其市场主导地位。同时，专业公司则在吻合器技术、微创稳定装置和新一代灌注系统等领域竞争。这种竞争平衡推动产品持续改进、临床证据不断累积以及针对性培训计画的发展，从而确保产品在外科团队中占据优先地位。

能够帮助製造商和医疗保健系统加快临床部署的切实有效的策略，增强医疗设备的韧性，并加强以价值主导的采购成果。

产业领导者应优先考虑一系列切实可行的策略，以协调产品开发、临床应用和供应链韧性。首先，应利用多中心和註册研究，投资产生将手术结果与特定器械获益联繫起来的证据，并建立引人入胜的临床案例。其次，应在产品设计中考虑模组化和互通性，以满足对整合式手术室生态系统和数据驱动型性能监测日益增长的需求。这些产品特性可以减少临床实务中的摩擦，并有助于医疗采购决策。

我们透过稳健透明的调查方法确保合法性，该方法结合了相关人员访谈、临床註册分析、监管审查和供应链评估。

本研究整合一手和二手资料，以确保结论和建议的证据全面且可重复。一手数据将透过对心臟外科医师、循环系统护理师、医院采购经理和医疗设备工程师进行结构化访谈获得，以了解手术偏好、对医疗设备性能的认知以及采购考量。除这些定性研究结果外，还将分析临床註册资料、同行评审的临床试验报告和监管申报文件，以全面检验医疗设备的安全性、手术结果和上市后监测讯号。

整合临床、技术和营运要求，为冠状动脉绕道手术 (CABG) 治疗中医疗设备的引进、创新和策略伙伴关係制定未来发展路径。

冠状动脉绕道手术手术（CABG）器械生态系统正处于临床创新、监管和供应链策略交汇的十字路口。外科团队不断改善手术流程，而器械开发商则积极回应，推出针对性创新，以增强手术控制、减轻生物负担并提高手术效率。同时，关税措施、报销方案调整和医院采购优先事项等外部压力，迫使製造商在产品生产地点和方式、定价以及售后支援等方面做出更谨慎的决策。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：冠状动脉绕道手术手术器械市场：依产品类型划分

  • 吻合装置
    • 压迫吻合环
    • 订书机
  • 心肺体外迴圈系统
    • 可携式系统
    • 标准体外循环机
  • 夹具和封口
    • 主动脉钳夹
    • 血管阻塞器
  • 固定装置
    • 机械固定装置
    • 吸力固定器

第九章：冠状动脉绕道手术手术器械市场（依移植类型划分）

  • 动脉移植
    • 乳内动脉
    • 桡动脉
  • 静脉移植

第十章：依手术方式冠状动脉绕道手术手术器械市场

  • 非泵送
  • 泵浦上

第十一章冠状动脉绕道手术手术器械市场：依最终用户划分

  • 门诊手术中心
  • 医院

第十二章冠状动脉绕道手术手术器械市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章冠状动脉绕道手术手术器械市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章冠状动脉绕道手术手术器械市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国冠状动脉绕道手术手术器械市场

第十六章：中国冠状动脉绕道手术手术器械市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Artivion, Inc.
  • AtriCure, Inc.
  • B. Braun SE
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Getinge AB
  • KLS Martin Group
  • LeMaitre Vascular, Inc.
  • LivaNova PLC
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Vascular Solutions, Inc.
  • WL Gore & Associates, Inc.
Product Code: MRR-6A132FD325F8

The Coronary Artery Bypass Graft Devices Market was valued at USD 15.86 billion in 2025 and is projected to grow to USD 16.81 billion in 2026, with a CAGR of 6.66%, reaching USD 24.92 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 15.86 billion
Estimated Year [2026] USD 16.81 billion
Forecast Year [2032] USD 24.92 billion
CAGR (%) 6.66%

A clear and authoritative orientation to the coronary artery bypass graft device landscape that frames clinical priorities technological evolution and stakeholder expectations

The coronary artery bypass graft device domain occupies a central role in cardiovascular surgery, balancing established surgical practice with persistent technological evolution. Clinicians continue to rely on proven techniques while device manufacturers and healthcare systems pursue incremental and disruptive innovations that improve procedural safety, reduce perioperative morbidity, and shorten recovery timelines. Against this backdrop, stakeholders now weigh clinical outcomes, ease of use, and supply chain resilience as equally important determinants of adoption decisions.

Recent advances in materials science, device ergonomics, and perfusion technology have reshaped clinical workflows, enabling teams to refine operative strategies and expand the treatment population. At the same time, regulatory scrutiny and payer requirements are prompting manufacturers to demonstrate robust evidence of procedural benefit and device reliability. As a result, the landscape is increasingly defined by the interplay of surgical technique preference, device capability, and institutional capacity to integrate new technologies into complex care pathways.

How clinical preference shifts technological integration and supply chain resilience are jointly reshaping device selection adoption and procurement strategies in CABG care

The landscape for coronary artery bypass graft devices is undergoing transformational shifts driven by converging clinical, technological, and operational forces. Minimally invasive approaches and off-pump techniques have stimulated demand for specialized anastomosis devices and stabilizers designed to facilitate precision in constrained operative fields, while improvements in cardiopulmonary bypass systems emphasize portability, biocompatibility, and reduced inflammatory response. These trends have redefined procurement criteria for surgical suites and cardiac centers, prompting institutions to evaluate capital acquisition against anticipated clinical gains and workflow efficiency.

Parallel to clinical innovation, digital augmentation and the rise of integrated operating room platforms are changing the expectations for device interoperability. Surgeons and perfusionists increasingly expect devices that support data capture, intraoperative visualization, and post-operative performance analytics. Consequently, manufacturers are investing in modular designs and connectivity features that enable better integration with hospital information systems and procedural analytics. Supply chain strategies have also adapted, with a renewed emphasis on dual-sourcing, localized manufacturing, and inventory optimization to mitigate disruptions and meet heightened regulatory compliance demands.

Assessment of the cumulative effects of the 2025 United States tariff measures on supply chain choices manufacturing localization and procurement practices for CABG devices

United States tariff policy introduced in 2025 has had a cumulative impact on coronary artery bypass graft device value chains, compelling manufacturers and purchasers to reassess sourcing and manufacturing footprints. Tariff escalation increased landed costs for imported device components and finished goods, which in turn affected procurement decisions across hospitals and ambulatory surgical centers. In response, several international suppliers recalibrated their commercial strategies by expanding regional manufacturing capacity, renegotiating supplier agreements, and accelerating investments in local assembly operations to preserve competitiveness.

Clinicians and hospital purchasing teams experienced operational implications as procurement windows tightened and lead-time variability increased. Some institutions prioritized devices with established local supply or those produced by manufacturers with nearshore facilities to ensure continuity of care. At a policy and industry level, there was a marked increase in dialogue between trade policymakers, medical device associations, and hospital consortia to explore tariff exemptions for clinical-critical components and to identify opportunities for incentivizing domestic production. The net effect has been a more intentional approach to supply chain risk management and a renewed focus on bilateral supplier relationships that balance cost, reliability, and regulatory compliance.

Multidimensional segmentation insights explaining how product type graft selection procedural modality and end user dynamics influence device development adoption and procurement

Segmentation of the coronary artery bypass graft device domain illuminates where innovation, clinical preference, and procurement focus converge. Based on Product Type, the landscape comprises Anastomosis Devices, Cardiopulmonary Bypass Systems, Clamps & Occluders, and Stabilizers, with Anastomosis Devices further distinguished by Compression Anastomosis Rings and Stapling Devices, Cardiopulmonary Bypass Systems subdivided into Portable Systems and Standard Heart-Lung Machines, Clamps & Occluders categorized into Aortic Clamps and Vascular Occluders, and Stabilizers segmented into Mechanical Stabilizers and Suction Stabilizers. This product-level granularity helps stakeholders match procedural requirements to device capabilities and assess trade-offs between single-use convenience and reusable capital equipment.

Based on Graft Type, the clinical and procurement conversation differentiates Arterial Grafts and Venous Grafts, with Arterial Grafts further examined through Internal Mammary Artery and Radial Artery use cases, and Venous Grafts represented primarily by the Saphenous Vein. These graft distinctions influence surgeon technique, device selection for anastomosis delivery, and perioperative management protocols. Based on Procedure Type, the dichotomy between Off-Pump and On-Pump approaches continues to shape the adoption curve for certain devices, as off-pump cases place a premium on stabilizers and anastomosis solutions that perform reliably in a beating-heart environment, while on-pump procedures create different perfusion and clamp requirements.

Based on End User, device adoption and purchasing dynamics diverge between Ambulatory Surgical Centers and Hospitals, with ambulatory settings often prioritizing devices that enable rapid turnover and simplified workflows, whereas hospitals weigh long-term capital utilization, support contracts, and cross-procedural versatility. Together, these segmentation lenses provide a multidimensional view that informs product development priorities, clinical training initiatives, and procurement negotiations.

Regional dynamics and differentiated adoption profiles across the Americas Europe Middle East Africa and Asia-Pacific shaping clinical practice and supplier strategy

Regional dynamics exert a strong influence on clinical practice patterns, regulatory pathways, and procurement strategies for coronary artery bypass graft devices. In the Americas, clinical centers often balance highly developed tertiary care networks with diverse procurement models that range from centralized group purchasing organizations to hospital-level sourcing, creating a competitive environment for suppliers that can provide clinical evidence and service support. In Europe, Middle East & Africa, regulatory harmonization efforts, varying reimbursement environments, and heterogeneous hospital capabilities shape differentiated adoption profiles where some high-volume centers lead clinical innovation while others prioritize cost containment and device reliability.

Across the Asia-Pacific region, rapid expansion of cardiovascular care capacity, investment in tertiary centers, and government-led manufacturing initiatives have reshaped demand patterns. Local manufacturing incentives, coupled with active clinical training programs, have accelerated adoption of both standard and portable cardiopulmonary systems. Transitional economies within the region balance access constraints with growing procedural volumes, which encourages suppliers to tailor commercial models that include managed services, training partnerships, and flexible financing. These regional distinctions highlight the necessity for manufacturers to adopt segmented go-to-market strategies that align clinical engagement, after-sales service, and regulatory expertise with local health system priorities.

Competitive and collaborative company dynamics highlighting how incumbents specialized innovators and new entrants drive product evolution clinical adoption and commercial differentiation

Competitive dynamics in the coronary artery bypass graft device arena reflect a mix of established multinational medical device corporations, specialized surgical device innovators, and agile startups introducing focused innovations. Established device manufacturers leverage extensive clinical relationships, integrated service networks, and regulatory experience to maintain installed base advantages, while specialized firms compete on innovation in staple anastomosis technologies, minimally invasive stabilizers, and next-generation perfusion systems. This competitive balance drives a continuous cycle of product refinement, clinical evidence generation, and targeted training programs to secure preference within surgical teams.

Strategic activity includes partnerships between device firms and hospital systems to pilot new technologies and collect real-world performance data, licensing agreements that broaden device availability, and vertical integration moves that bring consumables and capital equipment under common service contracts. Competitive pressure also incentivizes investment in value-added services such as remote device monitoring, clinician training modules, and consumable management. For new entrants, differentiation often hinges on demonstrating procedural efficiency, ease of adoption, and robust post-market clinical data that resonates with both surgeons and institutional procurement committees.

Practical high-impact strategies for manufacturers and health systems to accelerate clinical adoption enhance device resilience and strengthen value-driven procurement outcomes

Industry leaders should prioritize a set of actionable strategies to align product development, clinical adoption, and supply chain resilience. First, invest in evidence generation that couples procedural outcomes with device-specific advantages, leveraging multicenter clinical collaborations and registry-based studies to create compelling clinical narratives. Second, design products with modularity and interoperability in mind to meet the growing demand for integrated operating room ecosystems and data-driven performance monitoring. These product attributes reduce friction at the point of care and facilitate institutional procurement decisions.

Third, adopt supply chain diversification strategies that balance cost optimization with redundancy, including regional assembly, multiple qualified component suppliers, and scalable inventory management to address tariff-related uncertainties and logistical disruptions. Fourth, engage early and consistently with clinical champions and perfusion teams to build training curricula and onboarding programs that shorten the learning curve for new devices. Finally, explore commercial models that go beyond transactional sales-service contracts, outcome-based pricing pilots, and managed device programs can align incentives with health systems and create longer-term value. Together, these actions help manufacturers and healthcare providers navigate a rapidly evolving clinical and regulatory environment while preserving procedural quality and institutional budgets.

Robust and transparent research methodology combining stakeholder interviews clinical registry analysis regulatory review and supply chain evaluation to ensure defensible insights

This research synthesizes primary and secondary evidence sources to ensure a comprehensive, reproducible basis for conclusions and recommendations. Primary inputs include structured interviews with cardiac surgeons, perfusionists, hospital procurement leaders, and device engineers to capture procedural preferences, device performance perceptions, and procurement considerations. These qualitative insights were supplemented by analysis of clinical registries, peer-reviewed clinical trial reports, and regulatory filings to triangulate device safety profiles, procedural outcomes, and post-market surveillance signals.

Secondary research comprised a systematic review of relevant clinical literature, technical whitepapers, and manufacturer product specifications to map device feature sets and technological trajectories. Supply chain and trade policy analysis integrated customs and tariff schedules, public trade notices, and manufacturing investment announcements to assess sourcing implications. Data synthesis involved cross-validation of clinical claims against registry outcomes and reconciliation of stakeholder perspectives with documented regulatory events, producing a balanced and defensible understanding of device dynamics and strategic implications.

Synthesis of clinical technological and operational imperatives that define future pathways for device adoption innovation and strategic partnership in CABG care

The coronary artery bypass graft device ecosystem is at an inflection point where clinical innovation, regulatory scrutiny, and supply chain strategy intersect. Surgical teams continue to refine procedural techniques while device developers respond with targeted innovations that enhance procedural control, reduce physiological insult, and improve operational efficiency. At the same time, external pressures such as tariff measures, reimbursement dynamics, and hospital procurement priorities compel manufacturers to be more deliberate in where and how they manufacture, price, and support their products.

Looking forward, stakeholders who prioritize clinical evidence generation, device interoperability, and supply chain resilience will be better positioned to influence adoption decisions and sustain long-term partnerships with health systems. Cross-sector collaboration among clinicians, manufacturers, and payers will be essential to align technological potential with patient-centered outcomes and institutional imperatives. Ultimately, the most successful organizations will be those that combine technical excellence with pragmatic commercial models and demonstrable real-world performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Coronary Artery Bypass Graft Devices Market, by Product Type

  • 8.1. Anastomosis Devices
    • 8.1.1. Compression Anastomosis Rings
    • 8.1.2. Stapling Devices
  • 8.2. Cardiopulmonary Bypass Systems
    • 8.2.1. Portable Systems
    • 8.2.2. Standard Heart-Lung Machines
  • 8.3. Clamps & Occluders
    • 8.3.1. Aortic Clamps
    • 8.3.2. Vascular Occluders
  • 8.4. Stabilizers
    • 8.4.1. Mechanical Stabilizers
    • 8.4.2. Suction Stabilizers

9. Coronary Artery Bypass Graft Devices Market, by Graft Type

  • 9.1. Arterial Grafts
    • 9.1.1. Internal Mammary Artery
    • 9.1.2. Radial Artery
  • 9.2. Venous Grafts

10. Coronary Artery Bypass Graft Devices Market, by Procedure Type

  • 10.1. Off-Pump
  • 10.2. On-Pump

11. Coronary Artery Bypass Graft Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals

12. Coronary Artery Bypass Graft Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Coronary Artery Bypass Graft Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Coronary Artery Bypass Graft Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Coronary Artery Bypass Graft Devices Market

16. China Coronary Artery Bypass Graft Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Artivion, Inc.
  • 17.7. AtriCure, Inc.
  • 17.8. B. Braun SE
  • 17.9. BIOTRONIK SE & Co. KG
  • 17.10. Boston Scientific Corporation
  • 17.11. Cardinal Health, Inc.
  • 17.12. CryoLife, Inc.
  • 17.13. Edwards Lifesciences Corporation
  • 17.14. Getinge AB
  • 17.15. KLS Martin Group
  • 17.16. LeMaitre Vascular, Inc.
  • 17.17. LivaNova PLC
  • 17.18. Medtronic PLC
  • 17.19. Merit Medical Systems, Inc.
  • 17.20. MicroPort Scientific Corporation
  • 17.21. Teleflex Incorporated
  • 17.22. Terumo Corporation
  • 17.23. Vascular Solutions, Inc.
  • 17.24. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COMPRESSION ANASTOMOSIS RINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COMPRESSION ANASTOMOSIS RINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COMPRESSION ANASTOMOSIS RINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STAPLING DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STAPLING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STAPLING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PORTABLE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PORTABLE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PORTABLE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STANDARD HEART-LUNG MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STANDARD HEART-LUNG MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STANDARD HEART-LUNG MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY AORTIC CLAMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY AORTIC CLAMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY AORTIC CLAMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VASCULAR OCCLUDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VASCULAR OCCLUDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VASCULAR OCCLUDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY MECHANICAL STABILIZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY MECHANICAL STABILIZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY MECHANICAL STABILIZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SUCTION STABILIZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SUCTION STABILIZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SUCTION STABILIZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY INTERNAL MAMMARY ARTERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY INTERNAL MAMMARY ARTERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY INTERNAL MAMMARY ARTERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY RADIAL ARTERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY RADIAL ARTERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY RADIAL ARTERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY OFF-PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY OFF-PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY OFF-PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ON-PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ON-PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ON-PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. GCC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. GCC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. GCC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 166. GCC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 167. GCC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 168. GCC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 169. GCC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. GCC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 171. GCC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. GCC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. G7 CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. G7 CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. G7 CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 196. G7 CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 197. G7 CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 198. G7 CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 199. G7 CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. G7 CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 201. G7 CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. G7 CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. NATO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. NATO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. NATO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 206. NATO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 207. NATO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 208. NATO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 209. NATO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. NATO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 211. NATO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. NATO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)